Phase 1/2 study of AMG 531 in thrombocytopenic patients (pts) with low-risk Myelodysplastic syndrome (MDS): Update including extended treatment Meeting Abstract
| Authors: | Kantarjian, H.; Fenaux, P.; Sekeres, M. A.; Becker, P.; Boruchov, A.; Bowen, D.; Larson, R.; Lyons, R.; Muus, P.; Shammo, J.; Ehrman, M.; Hu, K.; Nichol, J. |
| Abstract Title: | Phase 1/2 study of AMG 531 in thrombocytopenic patients (pts) with low-risk Myelodysplastic syndrome (MDS): Update including extended treatment |
| Meeting Title: | 49th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 110 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2007 Dec 8-11 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2007-11-01 |
| Start Page: | 81A |
| Language: | English |
| ACCESSION: | WOS:000251100800251 |
| PROVIDER: | wos |
| PUBMED: | 18092369 |
| DOI: | 10.1182/blood.V110.11.250.250 |
| Notes: | --- - Meeting Abstract: 250 - 49th Annual Meeting of the American-Society-of-Hematology - DEC 08-11, 2007 - Atlanta, GA - Part 1 - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
